CA2244001A1 - Novel steroid carbamates as potentiating agents - Google Patents

Novel steroid carbamates as potentiating agents

Info

Publication number
CA2244001A1
CA2244001A1 CA002244001A CA2244001A CA2244001A1 CA 2244001 A1 CA2244001 A1 CA 2244001A1 CA 002244001 A CA002244001 A CA 002244001A CA 2244001 A CA2244001 A CA 2244001A CA 2244001 A1 CA2244001 A1 CA 2244001A1
Authority
CA
Canada
Prior art keywords
carbamate
benzyl
propyl
steroid
oconr1r2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002244001A
Other languages
French (fr)
Other versions
CA2244001C (en
Inventor
Satish Batra
Jan-Inge Carlsson
Thomas Fex
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600229A external-priority patent/SE9600229D0/en
Application filed by Individual filed Critical Individual
Publication of CA2244001A1 publication Critical patent/CA2244001A1/en
Application granted granted Critical
Publication of CA2244001C publication Critical patent/CA2244001C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Novel potentiating steroid carbamates having the general formula (I) ST-OCONR1R2 (I) wherein ST is a steroid or steroid derivative, of the structure (II)
CA002244001A 1996-01-23 1997-01-17 Novel steroid carbamates as potentiating agents Expired - Fee Related CA2244001C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600229A SE9600229D0 (en) 1996-01-23 1996-01-23 Novel potentiating agents
SE9600229-0 1996-01-23
PCT/SE1997/000066 WO1997027211A1 (en) 1996-01-23 1997-01-17 Novel steroid carbamates as potentiating agents

Publications (2)

Publication Number Publication Date
CA2244001A1 true CA2244001A1 (en) 1997-07-31
CA2244001C CA2244001C (en) 2007-06-05

Family

ID=38137608

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002244001A Expired - Fee Related CA2244001C (en) 1996-01-23 1997-01-17 Novel steroid carbamates as potentiating agents

Country Status (1)

Country Link
CA (1) CA2244001C (en)

Also Published As

Publication number Publication date
CA2244001C (en) 2007-06-05

Similar Documents

Publication Publication Date Title
CA2257016A1 (en) Imidazolidin-4-one derivatives useful as anticancer agents
CA2209001A1 (en) Hydrophobic taxane derivatives
EP0363212A3 (en) Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
KR920002596A (en) Azibicyclo derivatives
EP0664289A3 (en) Isoquinolines
EP1623985A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
CA2146238A1 (en) Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
CA2321547A1 (en) Indole derivatives and medicinal compositions containing the same
CA2002834A1 (en) Cycloalkyl xanthines
CA2219070A1 (en) Methods of preventing breast cancer
DE68909548D1 (en) ORGANIC HYDRAZINE COMPOUNDS FOR PHARMACEUTICAL APPLICATION.
ZA97444B (en) Potentiating agents.
CA2258725A1 (en) Analogues or derivatives of quercetin (prodrugs)
CA2126518A1 (en) Use of phenalkylamines
CA2003856A1 (en) Therapeutic agent for renal disorders
CA2235298A1 (en) Isoxazole derivatives
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
CA2244001A1 (en) Novel steroid carbamates as potentiating agents
CA2164642A1 (en) Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
CA2032254A1 (en) Glycerol Derivatives, a Preparation Process of the Same and Therapeutical Compositions Containing Them
CA2390296A1 (en) Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
CA2384184A1 (en) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties
CA2205664A1 (en) Indole derivatives and medicinal use thereof
BG101884A (en) Salts of the clavulanic acid
CA2011238A1 (en) Pharmaceutical treatment

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed